Emerging Microbes and Infections, 2022 Shigellosis appears to increase in certain at-risk populations in developed countries. Based on the nationwide surveillance, the annual incidence of shigellosis in Taiwan (1999-2019) was 0.38-5.77 cases per 100,000 people.
Chin-Shiang Tsai +15 more
doaj +1 more source
Frequency and antimicrobial susceptibility of Shigella species isolated in Children Medical Center Hospital, Tehran, Iran, 2001-2006 [PDF]
, 1906 Appropriate antimicrobial treatment of shigellosis depends on identifying its changing resistance pattern over time. We evaluated 15,255 stool culture submitted from July 2001 to June 2006 to the Laboratory of Children Medical Center Hospital.
Pourakbari, Babak +6 more
core +1 more source
Shigella flexneri vaccine development: Oral administration of peptides derived from the 49.8 kDa pili protein subunit activates the intestinal immune response in mice [PDF]
Veterinary World, 2022 Background and Aim: The morbidity and mortality of Shigella infections remain a global challenge. Epitope-based vaccine development is an emerging strategy to prevent bacterial invasion.
Khoirul Anam +5 more
doaj +1 more source
The Multifaceted Activity of the VirF Regulatory Protein in the Shigella Lifestyle [PDF]
, 2016 Shigella is a highly adapted human pathogen, mainly found in the developing world and causing a severe enteric syndrome. The highly sophisticated infectious strategy of Shigella banks on the capacity to invade the intestinal epithelial barrier and cause ...
Colonna, Bianca +4 more
core +3 more sources
A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology. [PDF]
PLoS Medicine, 2006 The burden of shigellosis is greatest in resource-poor countries. Although this diarrheal disease has been thought to cause considerable morbidity and mortality in excess of 1,000,000 deaths globally per year, little recent data are available to guide ...
Lorenz von Seidlein +17 more
doaj +1 more source
Protocol for a Scoping/Systematic Review: Scoping Review of Vaccination for the Prevention of Calf Scours in Cow-Calf Operations [PDF]
, 2020 Background: The use of antimicrobials in the livestock industry has been a topic of increasing concern in the last few years. Calf scours is one of the main causes of mortality among calves younger than 1 month and affects the development of the animal,
Breitenbuecher, Jefferson GC +4 more
core
Antibiotic therapy in acute diarrhea associated with Shigella: what is the best option? [PDF]
, 2012 Universidade Federal de São Paulo (UNIFESP)Centro Universitário Fundação e Instituto de Educação de Osasco Departamento de Ciências da Saúde Instituto de Pesquisa UnolabUNIFESP Departamento de PediatriaUNIFESP, Depto.
Carrari, Marina H. C. +2 more
core +2 more sources
Emerging Infectious Diseases, 2016 Shigella spp. cause ≈500,000 illnesses in the United States annually, and resistance to ciprofloxacin, ceftriaxone, and azithromycin is emerging. We investigated associations between transmission route and antimicrobial resistance among US shigellosis ...
Anna Bowen +5 more
doaj +1 more source
An Oral Inoculation Infant Rabbit Model for
mBio, 2020 Shigella species cause diarrheal disease globally. Shigellosis is typically characterized by bloody stools and colitis with mucosal damage and is the leading bacterial cause of diarrheal death worldwide.
Carole J. Kuehl +3 more
doaj +1 more source
Oral cholera vaccine use in Zanzibar: socioeconomic and behavioural features affecting demand and acceptance [PDF]
, 2009 Background Cholera remains a serious public health problem in low-income countries despite efforts in the past to promote oral rehydration therapy as major treatment.
Christian Schaetti +49 more
core +1 more source